Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American College of Gastroenterology (ACG) Annual Scientific Meeting

/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, today announced that five scientific abstracts on the clinical...

Related Keywords

California ,United States ,Charlotte ,North Carolina ,Dublin ,Ireland ,Americans ,Ryan Taylor ,K Rajender Reddy ,R Todd Frederick ,Xingyue Huang ,Heather Guzzi ,Robert Wong ,Prashant Pandya ,Khurram Jamil ,Prnewswire Mallinckrodt ,Danielj Speciale ,Nikolaos Pyrsopoulos ,Derek Belz ,Mallinckrodt Pharmaceuticals ,Clinical Development Critical Care ,National Organization For Rare Disorders ,Renal Drugs Advisory Committee ,California Pacific Medical Center ,United States Census Bureau ,Exchange Commission ,American College Of Gastroenterology ,Green Room Communications ,Mallinckrodt Pharmaceuticals Terlipressin Advisory Committee Briefing Document ,American College ,Annual Scientific Meeting ,Important Safety Information ,Boxed Warning ,Presidential Poster ,Vice President ,Clinical Development ,Economic Burden ,Patients With ,With Current Standard ,Retrospective Analysis ,Real World ,Terlipressin Treatment ,Patients With Hepatorenal Syndrome Type ,Renal Replacement Therapy ,Transplant Recipients ,Month Follow Up ,Treatment Response ,Terlipressin Plus Albumin Varies ,Precipitating Factor ,Hepatorenal Syndrome Type ,Serum Sodium Levels ,Increasing Burden ,Hepatorenal Syndrome ,Associated With High In Hospital Mortality ,Increased Healthcare Resource ,Fatal Respiratory Failure ,Liver Transplant ,Fetal Toxicity ,Prescribing Information ,Specialty Brands ,Specialty Generics ,Investor Relations ,Annual Report ,Green Room ,Renal Drugs Advisory ,Nationwide Inpatient Sample ,States Census Bureau ,Current Management ,Acute Kidney Injury ,Mallinckrodt Plc ,